Whole exome sequencing (WES) offers a comprehensive approach, sequencing the exons of all protein-coding genes plus thousands of known disease causing variants and the mitochondrial genome. With WES you can identify potential disease-causing variants that may have been missed by previous tests. While the exome represents only 1-2% of the human genome, it contains approximately 85% of the known disease-related variants.
myLifeExome reports contain primary findings, incidental findings and carriership findings.
Variant Type | Definition | myLifeExome |
---|---|---|
Single nucleotide variants (SNVs) |
A DNA sequence variant affecting 1 nucleotide | All protein-coding |
Insertion / Deletion (In-dels) |
Deletions, insertions, or duplications of DNA segments less than 500bp | All protein-coding |
Copy number variants (CNVs) |
Deletions or duplications of DNA segments of at least 500bp | Limited |
Structural variants (SVs) |
Insertions of DNA segments of at least 500bp, inversions and translocations (including translocations between nDNA and mtDNA) | Limited |
Repeat expansions | Increase in the number of repeated DNA sequence motifs within a gene | No |
Chromosomal abnormalities | Monosomy, trisomy, uniparental disomy, triploidy | All |
This test was developed by Arcensus laboratory.
Up to 20 working days from sample receipt
Twist Human Core Exome + RefSeq spike-in + Mitochondrial Panel
Mean coverage: min. 100x, 99,7% of target is covered by min 20x
Next-generation sequencing: Illumina NovaSeq 6000 or NovaSeqX (Plus)
Single-nucleotide variants, small insertions & deletions, copy number and mitochondrial variants
We accept buccal swabs, blood, DBS cards, saliva and isolated DNA*
* Arcensus only accepts isolated or extracted nucleic acids for which extraction or isolation is performed in an appropriately qualified laboratory.